Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness

J Thromb Haemost. 2012 Jun;10(6):1072-80. doi: 10.1111/j.1538-7836.2012.04717.x.

Abstract

Background: Fibrinogen contains an alternatively spliced γ-chain (γ'), which mainly exists as a heterodimer with the common γA-chain (γA/γ'). Fibrinogen γ' has been reported to inhibit thrombin and modulate fibrin structure, but the underlying mechanisms are unknown.

Objective: We aimed to investigate the molecular mechanism underpinning the influence of γ' on fibrin polymerization, structure and viscoelasticity.

Methods: γA/γA and γA/γ' fibrinogens were separated using anion exchange chromatography. Cross-linking was controlled with purified FXIIIa and a synthetic inhibitor. Fibrin polymerization was analyzed by turbidity and gel-point time was measured using a coagulometer. We used atomic force microscopy (AFM) to image protofibril formation while final clot structure was assessed by confocal and scanning electron microscopy. Clot viscoelasticity was measured using a magnetic microrheometer.

Results: γA/γ' fibrin formed shorter oligomers by AFM than γA/γA, which in addition gelled earlier. γA/γ' clots displayed a non-homogenous arrangement of thin fibers compared with the uniform arrangements of thick fibers for γA/γA clots. These differences in clot structure were not due to thrombin inhibition as demonstrated in clots made with reptilase. Non-cross-linked γA/γA fibrin was approximately 2.7 × stiffer than γA/γ'. Cross-linking by FXIIIa increased the stiffness of both fibrin variants; however, the difference in stiffness increased to approximately 4.6 × (γA/γA vs. γA/γ').

Conclusions: Fibrinogen γ' is associated with the formation of mechanically weaker, non-uniform clots composed of thin fibers. This is caused by direct disruption of protofibril formation by γ'.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Blood Coagulation Tests
  • Blood Coagulation*
  • Chromatography, Ion Exchange
  • Elasticity
  • Factor XIIIa / metabolism
  • Fibrin / metabolism*
  • Fibrin / ultrastructure
  • Fibrinogens, Abnormal / genetics
  • Fibrinogens, Abnormal / metabolism*
  • Humans
  • Microscopy, Atomic Force
  • Microscopy, Confocal
  • Microscopy, Electron, Scanning
  • Nephelometry and Turbidimetry
  • Polymerization
  • Protein Conformation
  • Structure-Activity Relationship
  • Time Factors
  • Viscosity

Substances

  • Fibrinogens, Abnormal
  • fibrinogen gamma'
  • Fibrin
  • Factor XIIIa